Eaton Vance Worldwide Health Sci R (ERHSX)
* As of 31-Mar-14
Quotes delayed, except where indicated otherwise. Currency in USD.
- No Headlines available for ERHSX at this time.
|Morningstar Overall Rating:|
|Annual Report Expense Ratio (net):||1.64%|
Performance & Risk
|5y Avg Return:||18.68%|
|Rank in Category (ytd):||46|
|% Rank in Category (ytd):||35.11%|
|Morningstar Risk Rating:||3|
The investment seeks long-term capital growth by investing in a worldwide and diversified portfolio of health sciences companies.
The fund normally invests at least 80% of its net assets in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care, including biotechnology, pharmaceuticals, diagnostics, managed health care and medical equipment and supplies. It concentrates (that is, invests at least 25% of its assets) its investments in medical research and the health care industry. The fund may invest up to 5% of its total assets in royalty bonds. View More